ResponderID™ KRAS: Biology-Driven Machine Learning to Personalize KRAS Inhibitor Therapeutics
Traditional biomarkers often fail to capture the dynamic nature [...]
Clinical Drug Discovery Veterans Join Genialis’ Efforts to Build Better Biomarkers for Precision Oncology
Class of new hires bring diverse expertise across numerous functions [...]
Genialis Maintains ISO 27001 Information Security Certification for Sixth Year
With another successful passing of the ISO/IEC 27001 external [...]
Genialis and BioLab Win Best Regular Paper at the 21st International Conference of Artificial Intelligence in Medicine
AIME 2023 Marco Ramoni Award-Winning Paper Describes a New [...]
To achieve personalized medicine, start by getting the dose right | TPM podcast #32
Welcome to Talking Precision Medicine (TPM podcast) — the [...]
Policymakers who want to regulate AI need to start talking to healthcare industry representatives
By Charles Fisher, Sarah Benson-Konforty, and Rafael Rosengarten Recently, the [...]
AI and Ethics in Healthtech: Who is Innovating Most? | Podcast #31
Welcome to Talking Precision Medicine — the podcast in [...]
Rafael Rosengarten joins the Midstage Startup Momentum Podcast with Roland Siebelink
"Build a Great Company and a Great Business Follows" [...]
Genialis Presents Poster on KRAS Expression Signature Validation in Lung Cancer
First research poster by Genialis on KRAS/MAPK therapeutic area [...]
Evaluation of a KRAS gene expression signature in lung cancer
This study evaluates the efficacy of a KRAS gene [...]
